• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES UK LIMITED Y-90 THERASPHERE (3 GBQ) CANADA COMM; MICROSPHERES RADIONUCLIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES UK LIMITED Y-90 THERASPHERE (3 GBQ) CANADA COMM; MICROSPHERES RADIONUCLIDE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Inflammation (1932); Jaundice (2187); Pancreatitis (4481); Unintended Radiation Exposure (4565)
Event Date 08/22/2021
Event Type  Injury  
Event Description
Proactif study.It was reported that pancreatitis occurred.In july 2021, the subject was enrolled into the proactif study and the treatment with therasphere was performed on the same day.Type of therasphere infusion was in the right anterior sector (segments v/viii).1.03 gbq was administered to the liver (ultra-selective) through vial 1 and 1.06 gbq was administered to the liver (ultra-selective) through vial 2.Total dose administered to the liver was 2.09 gbq.In august 2021, 30 days post index-procedure, the subject was hospitalized for abdominal pain with increased jaundice.The computed tomography (ct) scan was performed for further evaluation; indicated acute pancreatitis.Cholecystitis and radiation or ischemic cholangitis was noted, suspected to be due to embolization of the biliary arteries following radio embolization.The event was treated medically.Subject was made to fast, was hydrated and treated with acupan eps.The liver function was noted to improve spontaneously and subject no longer complained of pain.Six days later, the subject was discharged and the event was considered resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Y-90 THERASPHERE (3 GBQ) CANADA COMM
Type of Device
MICROSPHERES RADIONUCLIDE
Manufacturer (Section D)
BIOCOMPATIBLES UK LIMITED
chapman house farnham bus prk
weydon lane, farnham
surrey GU9 8 QL
UK  GU9 8QL
MDR Report Key12619084
MDR Text Key276453825
Report Number2134265-2021-12711
Device Sequence Number1
Product Code NAW
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial
Report Date 10/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received10/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient Weight56
-
-